New eczema pill shows promise in late-stage trial

This study tested an experimental oral drug called LNK01001 against a placebo in 356 adults with moderate to severe atopic dermatitis (eczema) who had not responded well to creams or other treatments. The goal was to see if the drug could improve skin clearing and reduce itching over 16 weeks. Participants were randomly assigned to receive either LNK01001 or a placebo, and neither they nor their doctors knew which they received.